Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Sparks

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Health Physics|February 16, 2002
Radioactivity appearing at landfills in household trash of nuclear medicine patients: much ado about nothing?Jeffry A Siegel, Richard B Sparks
Organic Letters|July 2, 2004
Microwave-assisted synthesis of 2,4,5-triaryl-imidazole; a novel thermally induced N-hydroxyimidazole N-O bond cleavageRichard B Sparks, Andrew P Combs
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicineMichael G Stabin, Richard B Sparks, Eric Crowe
Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Sensitivity of model-based calculations of red marrow dosimetry to changes in patient-specific parametersMichael G Stabin, Jeffry A Siegel, Richard B Sparks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2002
Calculating the absorbed dose from radioactive patients: the line-source versus point-source modelJeffry A Siegel, Carol S Marcus, Richard B Sparks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2003
Total-body and red marrow dose estimatesJeffry A Siegel, Michael G Stabin, Richard B Sparks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicityRichard B Sparks, Eric A Crowe, Franklin C Wong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2003
Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patientsJeffry A Siegel, Dion Yeldell, David M Goldenberg, et al.
Annals of Nuclear Medicine|July 10, 2025
Pharmacokinetics and dosimetry of [<sup>177</sup>Lu]Lu-PSMA-617 and [<sup>68</sup>Ga]Ga-PSMA-11 in Japanese patients with PSMA-positive mCRPCShoko Takano, Anri Inaki, Kenji Hirata, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2024
First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [<sup>68</sup>Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell CarcinomaMichael S Hofman, Ben Tran, Darren R Feldman, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Health Physics|February 16, 2002
Radioactivity appearing at landfills in household trash of nuclear medicine patients: much ado about nothing?Jeffry A Siegel, Richard B Sparks
Organic Letters|July 2, 2004
Microwave-assisted synthesis of 2,4,5-triaryl-imidazole; a novel thermally induced N-hydroxyimidazole N-O bond cleavageRichard B Sparks, Andrew P Combs
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicineMichael G Stabin, Richard B Sparks, Eric Crowe
Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Sensitivity of model-based calculations of red marrow dosimetry to changes in patient-specific parametersMichael G Stabin, Jeffry A Siegel, Richard B Sparks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2002
Calculating the absorbed dose from radioactive patients: the line-source versus point-source modelJeffry A Siegel, Carol S Marcus, Richard B Sparks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2003
Total-body and red marrow dose estimatesJeffry A Siegel, Michael G Stabin, Richard B Sparks
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicityRichard B Sparks, Eric A Crowe, Franklin C Wong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2003
Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patientsJeffry A Siegel, Dion Yeldell, David M Goldenberg, et al.
Annals of Nuclear Medicine|July 10, 2025
Pharmacokinetics and dosimetry of [<sup>177</sup>Lu]Lu-PSMA-617 and [<sup>68</sup>Ga]Ga-PSMA-11 in Japanese patients with PSMA-positive mCRPCShoko Takano, Anri Inaki, Kenji Hirata, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2024
First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [<sup>68</sup>Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell CarcinomaMichael S Hofman, Ben Tran, Darren R Feldman, et al.
Pageof 3